www.fdanews.com/articles/196869-icecures-tumor-freezing-device-approved-in-india
IceCure’s Tumor-Freezing Device Approved in India
April 29, 2020
IceCure’s ProSense system, a cryoablation device used to destroy cancerous tissue, has been approved for use in India.
The liquid nitrogen-based system is used to destroy benign and cancerous tumors in breast, lung, bone and kidney cancer.
The device can be used to freeze tumors in a doctor’s surgery or at a clinic in less than an hour, avoiding the need for hospitalization.